Novel Anticoagulants

Novel anticoagulants are newer medications designed to prevent blood clots, reducing the risk of strokes and deep vein thrombosis. Unlike traditional drugs like warfarin, they act quickly, require less monitoring, and have fewer food and drug interactions. They work on specific components of the clotting process, making them effective and convenient. Common examples include apixaban, rivaroxaban, and dabigatran. These medications are essential for patients at risk of abnormal clot formation, but must be used carefully under medical supervision to balance the benefits of preventing clots with the risk of bleeding.